ADAM E STRANTZ
- Type
- Non-physician practitioner · Physician Assistants & Advanced Practice Nursing Providers / Physician Assistant
- Where
- FREMONT, MI
- NPI
- 1316220437
- Received
- $2,930 in 167 records, 2021 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 20 | $441 |
| 2024 | General payment | 8 | $150 |
| 2023 | General payment | 26 | $490 |
| 2022 | General payment | 46 | $618 |
| 2021 | General payment | 67 | $1,229 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 43 | $742 | 2021–2025 |
| Supernus Pharmaceuticals, Inc. | 32 | $369 | 2021–2025 |
| Teva Pharmaceuticals USA, Inc. | 10 | $273 | 2021–2025 |
| ABBVIE INC. | 14 | $233 | 2021–2025 |
| Janssen Pharmaceuticals, Inc | 9 | $216 | 2021–2025 |
| Lundbeck LLC | 14 | $197 | 2021–2023 |
| Alkermes, Inc. | 8 | $178 | 2021–2025 |
| Otsuka America Pharmaceutical, Inc. | 7 | $136 | 2021–2025 |
| Neurocrine BioSciences, Inc. | 6 | $121 | 2021–2022 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $87 | 2021–2022 |
| Novo Nordisk Inc | 3 | $61 | 2021 |
| Vanda Pharmaceuticals Inc. | 3 | $59 | 2021–2025 |
| Sunovion Pharmaceuticals Inc. | 3 | $52 | 2021 |
| Axsome Therapeutics, Inc. | 2 | $46 | 2023–2025 |
| Alfasigma USA, Inc. | 2 | $30 | 2021 |
| Allergan, Inc. | 1 | $21 | 2021 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $20 | 2021 |
| Indivior Inc. | 1 | $18 | 2023 |
| Alexion Pharmaceuticals, Inc. | 1 | $17 | 2022 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 | 2023 |
| Eisai Inc. | 1 | $14 | 2021 |
| NESTLE HEALTHCARE NUTRITION INC. | 1 | $11 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 162 | $2,678 |
| Education | 5 | $251 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-05 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-12-04 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-11-06 | Teva Pharmaceuticals USA, Inc. | $19 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-10-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $104 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-02 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-10-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-04 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-08 | Alkermes, Inc. | $26 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-08-07 | Supernus Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-07-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $9 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-05 | Supernus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-05-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-20 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-06 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-03-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-06 | Vanda Pharmaceuticals Inc. | $24 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-02-06 | Supernus Pharmaceuticals, Inc. | $13 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-02-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $8 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-02 | Axsome Therapeutics, Inc. | $30 | Food and Beverage | In-kind items and services | Sunosi Drug, Neurology | 2025 | |
| 2025-01-02 | Supernus Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2024-09-11 | Alkermes, Inc. | $27 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-08-07 | Supernus Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-08-07 | Supernus Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-07-02 | Supernus Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-04-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-02-24 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-02-14 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-01-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2023-12-19 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-07 | Alkermes, Inc. | $16 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-10-11 | Janssen Pharmaceuticals, Inc | $80 | Education | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-09-27 | Supernus Pharmaceuticals, Inc. | $12 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-09-14 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-08-25 | Bayer Healthcare Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2023 | |
| 2023-08-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-07-20 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-06-21 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-06-07 | Janssen Pharmaceuticals, Inc | $19 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2023 | |
| 2023-05-24 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-04-12 | Indivior Inc. | $18 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-03-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-03-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-03-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $0 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-02-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-02-01 | Otsuka America Pharmaceutical, Inc. | $28 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-01-23 | Supernus Pharmaceuticals, Inc. | $17 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-01-18 | Axsome Therapeutics, Inc. | $15 | Food and Beverage | In-kind items and services | Sunosi Drug, Neurology | 2023 | |
| 2023-01-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-01-11 | Lundbeck LLC | $23 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-01-11 | Supernus Pharmaceuticals, Inc. | $15 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2022-12-15 | Janssen Pharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2022 | |
| 2022-12-13 | Supernus Pharmaceuticals, Inc. | $8 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-12-07 | Supernus Pharmaceuticals, Inc. | $18 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-11-17 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-11-16 | Supernus Pharmaceuticals, Inc. | $17 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-11-09 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-10-19 | Supernus Pharmaceuticals, Inc. | $11 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-10-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-10-13 | Supernus Pharmaceuticals, Inc. | $4 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-10-05 | Janssen Pharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2022 | |
| 2022-09-27 | Supernus Pharmaceuticals, Inc. | $8 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-09-14 | Supernus Pharmaceuticals, Inc. | $9 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-09-08 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-09-08 | Supernus Pharmaceuticals, Inc. | $4 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-09-01 | Supernus Pharmaceuticals, Inc. | $5 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-08-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-07-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-07-13 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-07-11 | Supernus Pharmaceuticals, Inc. | $23 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-07-06 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-06-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-06-27 | Supernus Pharmaceuticals, Inc. | $1 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-06-20 | Supernus Pharmaceuticals, Inc. | $4 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-06-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-06-13 | Supernus Pharmaceuticals, Inc. | $2 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-06-07 | Supernus Pharmaceuticals, Inc. | $3 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-06-01 | Supernus Pharmaceuticals, Inc. | $2 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-05-31 | Teva Pharmaceuticals USA, Inc. | $12 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2022 | |
| 2022-05-25 | Janssen Pharmaceuticals, Inc | $19 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2022 | |
| 2022-05-16 | Supernus Pharmaceuticals, Inc. | $4 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-05-11 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-05-04 | Neurocrine BioSciences, Inc. | $22 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-04-27 | Supernus Pharmaceuticals, Inc. | $9 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-04-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-04-13 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-04-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-04-06 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2022 | |
| 2022-03-03 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-03-02 | Alexion Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | STRENSIQ Biological, Rare Disease | 2022 | |
| 2022-03-02 | Supernus Pharmaceuticals, Inc. | $8 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-02-23 | Supernus Pharmaceuticals, Inc. | $4 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-02-16 | Supernus Pharmaceuticals, Inc. | $5 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-02-02 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2022 | |
| 2022-02-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-01-06 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-01-05 | Supernus Pharmaceuticals, Inc. | $24 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2021-12-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-12-21 | Lundbeck LLC | $9 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-12-02 | Lundbeck LLC | $6 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-12-01 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2021-11-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-11-24 | Lundbeck LLC | $16 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-11-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-11-12 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-11-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $72 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-10-28 | Takeda Pharmaceuticals U.S.A., Inc. | $24 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2021 | |
| 2021-10-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $7 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-10-26 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2021 | |
| 2021-10-22 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | RYBELSUS Drug, Diabetes | 2021 | |
| 2021-10-20 | Neurocrine BioSciences, Inc. | $13 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2021 | |
| 2021-10-20 | Lundbeck LLC | $12 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-10-19 | Teva Pharmaceuticals USA, Inc. | $24 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2021 | |
| 2021-10-19 | Lundbeck LLC | $11 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-10-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-10-06 | Supernus Pharmaceuticals, Inc. | $23 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2021 | |
| 2021-09-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-09-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Education | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-09-29 | Lundbeck LLC | $16 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-09-29 | Lundbeck LLC | $7 | Education | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-09-28 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-09-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-09-22 | Vanda Pharmaceuticals Inc. | $23 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2021 | |
| 2021-08-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-08-24 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2021 | |
| 2021-08-24 | Teva Pharmaceuticals USA, Inc. | $4 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2021 | |
| 2021-08-17 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-08-12 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-08-11 | Alfasigma USA, Inc. | $14 | Food and Beverage | In-kind items and services | 2021 | ||
| 2021-08-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-07-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $27 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-07-27 | IRONWOOD PHARMACEUTICALS, INC | $20 | Food and Beverage | Cash or cash equivalent | Linzess Drug, GI | 2021 | |
| 2021-07-20 | Sunovion Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2021 | |
| 2021-07-14 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2021 | |
| 2021-06-30 | Alfasigma USA, Inc. | $15 | Food and Beverage | In-kind items and services | 2021 | ||
| 2021-06-17 | Lundbeck LLC | $24 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-06-15 | Takeda Pharmaceuticals U.S.A., Inc. | $23 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2021 | |
| 2021-06-10 | Eisai Inc. | $14 | Food and Beverage | Cash or cash equivalent | Dayvigo Drug, Neurology | 2021 | |
| 2021-06-03 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | INVOKANA Drug, Cardiovascular & Metabolism | 2021 | |
| 2021-05-27 | Janssen Pharmaceuticals, Inc | $20 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2021 | |
| 2021-05-25 | Takeda Pharmaceuticals U.S.A., Inc. | $21 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2021 | |
| 2021-05-25 | Lundbeck LLC | $6 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-05-21 | Teva Pharmaceuticals USA, Inc. | $111 | Education | In-kind items and services | 2021 | ||
| 2021-05-20 | NESTLE HEALTHCARE NUTRITION INC. | $11 | Food and Beverage | In-kind items and services | ZENPEP Drug, ENDOCRINE PANCREATIC INSUFFICIENCY | 2021 | |
| 2021-05-18 | Sunovion Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2021 | |
| 2021-05-10 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2021 | |
| 2021-05-04 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-05-04 | Vanda Pharmaceuticals Inc. | $11 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2021 | |
| 2021-04-28 | Teva Pharmaceuticals USA, Inc. | $25 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2021 | |
| 2021-04-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-04-13 | Lundbeck LLC | $4 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-03-25 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-03-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-03-17 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-03-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $46 | Education | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-03-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-03-02 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-02-16 | Otsuka America Pharmaceutical, Inc. | $11 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-02-15 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2021 | |
| 2021-02-10 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-02-09 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-02-05 | Allergan, Inc. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-02-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $25 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-01-05 | Sunovion Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Fremont, MI, county Newaygo County, MI, state Michigan; placed by its city name.
| Measure | Place (city or town) Fremont, MI | County Newaygo County, MI | State Michigan |
|---|---|---|---|
| Population B01003 | 4,568 | 50,792 | 10,077,761 |
| Population, 2020 census P1 | 4,516 | 49,978 | 10,077,331 |
| Median age B01002 | 38.0 | 42.7 | 40.2 |
| Under 18 B01001 | 23.0% | 21.9% | 21.2% |
| 65 and over B01001 | 23.6% | 20.7% | 18.6% |
| Households B11001 | 1,950 | 19,651 | 4,076,369 |
| Foreign born B05002 | 2.6% | 2.1% | 7.2% |
| Median household income B19013 | $57,452 | $63,304 | $72,875 |
| Median family income B19113 | $70,692 | $75,218 | $93,357 |
| Per capita income B19301 | $33,550 | $31,564 | $40,735 |
| Poverty rate B17001 | 8.7% | 12.8% | 13.2% |
| Unemployment rate B23025 | 2.8% | 4.4% | 5.7% |
| Civilian labor force B23025 | 2,082 | 22,868 | 5,018,449 |
| Mean commute (minutes) B08013 | 21.1 | 30.6 | 24.2 |
| Bachelor's degree or higher B15003 | 29.4% | 18.1% | 32.4% |
| Housing units B25001 | 2,109 | 24,931 | 4,622,236 |
| Owner-occupied B25003 | 70.5% | 86.5% | 73.2% |
| Renters B25003 | 29.5% | 13.5% | 26.8% |
| Median home value B25077 | $194,700 | $186,700 | $231,600 |
| Median gross rent B25064 | $730 | $904 | $1,129 |
| White, not Hispanic B03002 | 91.6% | 87.2% | 72.4% |
| Black B03002 | 0.0% | 0.8% | 13.1% |
| Hispanic or Latino B03002 | 6.1% | 6.3% | 5.9% |
| Asian B03002 | 0.5% | 0.4% | 3.4% |
| American Indian and Alaska Native B03002 | 0.0% | 0.3% | 0.3% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Fremont, MI.
Comments